Summit Trail Advisors’s BioVie BIVI Stock Holding History

Summit Trail Advisors’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-101	Closed	-$5.34K	–	622
2024 Q1	$5.34K	Hold	101	–	–	﹤0.01%	613
2023 Q4	$12.7K	Hold	101	–	–	﹤0.01%	557
2023 Q3	$34.4K	Buy	+101	New	+$39.5K	﹤0.01%	540

Other funds holding BIVI

ACM

Altium Capital Management New York $42M AUM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Summit Trail Advisors's BIVI Position: Q2 2024 in Review

Summit Trail Advisors sold out of BioVie (BIVI) in Q2 2024, closing a stake of 101 shares — an estimated $5.34K sold.

Summit Trail Advisors first reported a position in BIVI in Q3 2023 and held it in 3 quarters. The position peaked at $34.4K in Q3 2023. 48 funds tracked by Wall St. Rank hold BIVI as of Q2 2024.

Summit Trail Advisors reported no remaining BioVie position as of Q2 2024 after selling out during the quarter.
Summit Trail Advisors sold 101 BioVie shares in Q2 2024, an estimated $5.34K.
Summit Trail Advisors first reported a position in BioVie in Q3 2023 and held it in 3 quarters.
Summit Trail Advisors's BioVie position peaked at $34.4K in Q3 2023.
48 funds tracked by Wall St. Rank held BioVie as of Q2 2024.

Based on Summit Trail Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.